- Patient Education: Video
NCI National Cancer Institute: Manufacturing CAR T Cells to Accelerate Cancer Immunotherapy Research
Updated: Apr 7, 2022
NCI National Cancer Institute: Manufacturing CAR T Cells to Accelerate Cancer Immunotherapy Research
Manufacturing CAR T Cells to Accelerate Cancer Immunotherapy Research
An example of CART Cell therapy approved by FDA to treat relapsed & refractory Multiple Myeloma is
Idecabtagene Vicleucel ( Abecma)